Shweta Singh

Person

Fremont, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for conjugating activatable antibodies
- Patent number 11,992,528
- Issue date May 28, 2024
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...
- Patent number 11,753,466
- Issue date Sep 12, 2023
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods...
- Patent number 11,267,896
- Issue date Mar 8, 2022
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...
- Patent number 10,745,481
- Issue date Aug 18, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...
- Patent number 10,577,420
- Issue date Mar 3, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and metho...
- Patent number 10,233,244
- Issue date Mar 19, 2019
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods...
- Patent number 10,179,817
- Issue date Jan 15, 2019
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
C10RF32 antibodies, and uses thereof for treatment of cancer
- Patent number 9,617,336
- Issue date Apr 11, 2017
- COMPUGEN LTD
- Gady S. Cojocaru
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for conjugating activatable antibodies
- Patent number 9,517,276
- Issue date Dec 13, 2016
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE T...
- Publication number 20240115724
- Publication date Apr 11, 2024
- ABBVIE INC.
- Shweta SINGH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...
- Publication number 20240076374
- Publication date Mar 7, 2024
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD83 CAR-T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION
- Publication number 20230331841
- Publication date Oct 19, 2023
- CRISPR Therapeutics AG
- Daniel Robert HOSTETTER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...
- Publication number 20220306759
- Publication date Sep 29, 2022
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES
- Publication number 20220088192
- Publication date Mar 24, 2022
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE T...
- Publication number 20210145978
- Publication date May 20, 2021
- ABBVIE INC.
- Shweta Singh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...
- Publication number 20200291113
- Publication date Sep 17, 2020
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER
- Publication number 20200002416
- Publication date Jan 2, 2020
- Compugen, LTD
- Gady S. COJOCARU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHO...
- Publication number 20190309072
- Publication date Oct 10, 2019
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...
- Publication number 20190202927
- Publication date Jul 4, 2019
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE T...
- Publication number 20190111150
- Publication date Apr 18, 2019
- ABBVIE INC.
- Shweta SINGH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER
- Publication number 20170233473
- Publication date Aug 17, 2017
- COMPUGEN LTD.
- Gady S. COJOCARU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES
- Publication number 20170072067
- Publication date Mar 16, 2017
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...
- Publication number 20160355587
- Publication date Dec 8, 2016
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHO...
- Publication number 20160355592
- Publication date Dec 8, 2016
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...
- Publication number 20160355599
- Publication date Dec 8, 2016
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER
- Publication number 20150158947
- Publication date Jun 11, 2015
- COMPUGEN LTD.
- Gady S. Cojocaru
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES
- Publication number 20150005477
- Publication date Jan 1, 2015
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Shweta Singh

Person

Patents Grantslast 30 patents

Compositions and methods for conjugating activatable antibodies

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...

Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods...

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...

Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and metho...

Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods...

C10RF32 antibodies, and uses thereof for treatment of cancer

Compositions and methods for conjugating activatable antibodies

Patents Applicationslast 30 patents

ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE T...

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...

ANTI-CD83 CAR-T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUPTION

ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...

COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES

ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE T...

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...

C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER

ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHO...

ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...

ANTI-CD71 ACTIVATABLE ANTIBODY DRUG CONJUGATES AND METHODS OF USE T...

C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...

ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHO...

ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS...

C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES